Delivery Order SPE2DB22D9143-SPE2DB24FZC12

Award Date 6/3/24
Potential Completion Date 6/25/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $23,684.40, is for the delivery of MITOSOL 0.2MG KITS 3S and has a period of performance through June 28, 2024. This order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA,...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $1,315.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Mitosol 0.2mg kits, a pharmaceutical product, with a period of performance through April 4, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract 4600082013 with the DLA, valued at up...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,158 contract is for the delivery of MITOSOL 0.2 MG kits to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group that covers a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $6,579.00, is for the delivery of MITOSOL 0.2 MG KITS with a period of performance through March 29, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, contract number SPE2DB24FYN58, with a ceiling value of up to $4,999,999 that DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,526.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through November 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract with the DLA under the SPE2DB program to provide a broad range of...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $5,263.24 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of MITOSOL 0.2 MG KITS. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with DLA, valued up to $499,999,999, that allows the agency to issue orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $26,316.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of MITOSOL 0.2 MG KITS and has a ceiling value of $26,316.00 with a performance period ending on December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of MITOSOL 0.2 MG KITS. The contract, which has a potential value of $7,894.80, has a completion date of March 11, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of brand and generic prescription and over-the-counter drug supplies to government...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,315.80 with a firm fixed-price pricing type and a period of performance through February 24, 2025. The contract covers the delivery of MITOSOL 0.7 MG KITS, a pharmaceutical product, to support the medical supply needs of military healthcare facilities. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,947.40, is for the delivery of Mitosol 0.2 mg kits, a pharmaceutical product. The contract has a firm fixed price and runs through May 15, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
  • SPE2DB22D9143
    Indefinite Delivery Contract
  • SPE2DB22D9143-SPE2DB24FZC12
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $7,894.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4564839855 kits of the drug Mitosol (mitomycin) 0.2 mg. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows the DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.

Generated 9/2/24, 3:37 PM